Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00844246 · ClinicalTrials.gov registry record · Phase 2

Translating Evidence Based Developmental Screening Into Pediatric Primary Care

A Phase 2 study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
Phase 2
Development phase
2,314
Enrollment target

NCT00844246 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 2,314 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00844246, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
Phase 2
Development phase
2,314 participants
Enrollment target

Study Summary

The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age.

Interventions

  • OTHER Developmental screening using ASQ and MCHAT

Trial Details

FieldValue
Enrollment Target 2,314 participants
Start Date 2008-11
Est. Completion 2010-10
Phase Phase 2

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT00844246

The ClinicalTrials.gov registry entry for NCT00844246 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Developmental screening using ASQ and MCHAT is the first listed.

NCT00844246 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00844246 about?

NCT00844246 is a clinical study titled "Translating Evidence Based Developmental Screening Into Pediatric Primary Care". The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical development...

What is the current status of trial NCT00844246?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,314 participants. The study started on 2008-11. Estimated completion is 2010-10.

What interventions are being tested in trial NCT00844246?

The interventions under investigation include: Developmental screening using ASQ and MCHAT (OTHER).

Who is sponsoring clinical trial NCT00844246?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.